Cellular plasticity contributes to intratumoral heterogeneity, metastatic spread, and treatment resistance of cancers. In this issue of Cancer Cell, Gabitova-Cornell et al. identify the potential to inadvertently develop an undifferentiated and more aggressive pancreas cancer with agents commonly prescribed to manage heart disease risk.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976615 | PMC |
http://dx.doi.org/10.1016/j.ccell.2020.09.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!